MyFinsight
Home
Blog
About
Contact
Download
Download image
Attributable to
non-controlling interests
-$39,730K
Net loss
attributable to common...
-$1,882K
Net income (loss)
attributable to fortress
$6,815K
Net loss
-$32,915K
Income tax expense
(benefit)
-$620K
Gain from
deconsolidation of subsidiary
$27,127K
Other income
$17,578K
Avenue Therapeutics
Inc
$1,404K
Journey
$619K
Interest income
$2,485K
Preferred a dividends
declared and paid and/or...
$8,697K
Loss before income
tax expense
-$33,535K
Total other income
(expense)
$36,686K
Product revenue, net
$61,239K
Other revenue
$2,023K
Interest expense and
financing fee
$10,106K
Loss on common stock
warrant liabilities
-$398K
Loss from operations
-$70,221K
Net revenue
$63,262K
Total operating
expenses
$133,483K
Selling, general and
administrative
$96,400K
Cost of goods -
(excluding amortization of...
$20,924K
Research and development
$11,901K
Amortization of acquired
intangible assets
$4,258K
Back
Back
Income Statement
source: myfinsight.com
Fortress Biotech, Inc. (FBIOP)
Fortress Biotech, Inc. (FBIOP)